Understanding our eugenic past to take steps towards scientific accountability
By Rori Rohlfs,
Genes to Genomes
| 06. 08. 2020
Because genetic determinism is an implicit and stealth component of our academic inheritance, even well-meaning scientists working at respected institutions can unwittingly pursue research that supports eugenicist arguments.
I was a fourth-year graduate student when I found myself asking a librarian for the archives of the journal The Annals of Eugenics. I got to that point by climbing back through a chain of references on fundamental statistical measures in my field of population genetics. I held the journal and flipped through the article titles and familiar author names, realizing that my field wasn’t so far removed from the turn-of-the-century eugenics movement. Feeling somewhat nauseous, I photocopied the article I was looking for and returned the journal quickly.
Now as a faculty member at San Francisco State University (SFSU), a public institution that puts social justice at the center of its mission, I continue to struggle with my field’s limited reckoning with our eugenic past. Can folks like me, who have built careers that grow from eugenics science, hold ourselves accountable for these roots as we continue scientific research? These questions become increasingly important in a political landscape where scientific ideas about genetic variation and difference are weaponized to support devastating policies, and the atrocities of racial injustice...
Related Articles
By Hannah Devlin, The Guardian | 05.23.2025
The sperm of a man carrying a rare cancer-causing mutation was used to conceive at least 67 children, 10 of whom have since been diagnosed with cancer, in a case that has highlighted concerns about the lack of internationally agreed...
By Katie Sagaser, The DNA Exchange | 05.27.2025
Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my employer, past or present, or any affiliated institutions. This content is provided for general informational purposes only and does not...
By Mariam E Sunny and Siddhi Mahatole, Reuters | 05.19.2025
Regeneron Pharmaceuticals (REGN.O), opens new tab said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from customers using ancestry testing and other...
By Laura Ungar, Associated Press | 04.26.2025
Emily Kramer-Golinkoff can’t get enough oxygen with each breath. Advanced cystic fibrosis makes even simple things like walking or showering arduous and exhausting.
She has the most common fatal genetic disease in the U.S., which afflicts 40,000 Americans. But her...